Activity of levofloxacin, ofloxacin, D-ofloxacin and ciprofloxacin against systemic and respiratory tract infections in laboratory animals.
Hoechst AG Pharma Research, Frankfurt/Main, Germany.
N
N
Klesel
K H
KH
Geweniger
P
P
Koletzki
D
D
Isert
M
M
Limbert
A
A
Markus
G
G
Riess
H
H
Schramm
G
G
Seibert
P
P
Iyer
D000818:Animals; D000890:Anti-Infective Agents / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control; D015169:Colony Count, Microbial; D024841:Fluoroquinolones; D007710:Klebsiella Infections / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D051379:Mice; D011018:Pneumonia, Pneumococcal / Q000188:drug therapy / Q000382:microbiology / Q000517:prevention & control; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology / Q000517:prevention & control
D000890:Anti-Infective Agents; D024841:Fluoroquinolones